These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2899377)

  • 1. Antipsychotic withdrawal symptoms: phenomenology and pathophysiology.
    Dilsaver SC; Alessi NE
    Acta Psychiatr Scand; 1988 Mar; 77(3):241-6. PubMed ID: 2899377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic withdrawal phenomena in the medical-surgical setting.
    Dilsaver SC; Coffman JA
    Gen Hosp Psychiatry; 1988 Nov; 10(6):438-46. PubMed ID: 2904918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.
    Dilsaver SC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):137-61. PubMed ID: 1968671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal phenomena associated with antidepressant and antipsychotic agents.
    Dilsaver SC
    Drug Saf; 1994 Feb; 10(2):103-14. PubMed ID: 7912078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitor withdrawal phenomena: symptoms and pathophysiology.
    Dilsaver SC
    Acta Psychiatr Scand; 1988 Jul; 78(1):1-7. PubMed ID: 2845711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyserositis, acute withdrawal, and relapse after abrupt clozapine discontinuation.
    Malhotra S; Franco K; Tomford JW; Iqbal R
    Psychosomatics; 2002; 43(5):418-20. PubMed ID: 12297612
    [No Abstract]   [Full Text] [Related]  

  • 9. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 11. Exacerbation of psychotic symptoms due to benzodiazepine withdrawal.
    Özdemir O; Atilla E
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E23-4. PubMed ID: 25093773
    [No Abstract]   [Full Text] [Related]  

  • 12. Why is it so difficult to stop psychiatric drug treatment? It may be nothing to do with the original problem.
    Moncrieff J
    Med Hypotheses; 2006; 67(3):517-23. PubMed ID: 16632226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
    Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
    Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of neuroleptics in use in the United States.
    Richelson E
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):8-14. PubMed ID: 2862140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Indications for, limitations, and hazards of neuroleptic agents].
    Hoes MJ
    Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304
    [No Abstract]   [Full Text] [Related]  

  • 16. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenomenology and therapy of neuroleptic-induced akathisia--a review of the literature].
    Seidel M
    Fortschr Neurol Psychiatr; 1989 Nov; 57(11):489-94. PubMed ID: 2574702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticholinergics during neuroleptic treatment. Value and withdrawal].
    Betermiez P; Delahousse J; Pedinielli JL
    Encephale; 1986; 12(4):169-74. PubMed ID: 2878801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant withdrawal phenomena.
    Dilsaver SC; Greden JF
    Biol Psychiatry; 1984 Feb; 19(2):237-56. PubMed ID: 6324897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.